TOT BIOPHARM International Company Limited (HKG:1875)
Hong Kong · Delayed Price · Currency is HKD 1.900
0.00 (0.00%)
Jul 16, 2025, 3:50 PM HKT
HKG:1875 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | 34.76 | -37.76 | -49.92 | -261.22 | -288.5 | Upgrade |
Depreciation & Amortization | 62.84 | 41.3 | 36.42 | 33.1 | 31.23 | Upgrade |
Other Amortization | 2.58 | 1.73 | 1.62 | 1.14 | 0.86 | Upgrade |
Loss (Gain) From Sale of Assets | 0.99 | 3.42 | 2.36 | 5 | -0.58 | Upgrade |
Asset Writedown & Restructuring Costs | - | 7.15 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | - | -0.94 | -0.91 | - | -2.21 | Upgrade |
Loss (Gain) on Equity Investments | - | 2.5 | 6.63 | 0.02 | - | Upgrade |
Stock-Based Compensation | 6.01 | 10.64 | 16.11 | 5.3 | 15.83 | Upgrade |
Provision & Write-off of Bad Debts | 1.05 | -0.32 | 0.6 | - | - | Upgrade |
Other Operating Activities | 0.83 | 16.97 | 6.47 | 2.47 | -0.09 | Upgrade |
Change in Accounts Receivable | -49.41 | -82.55 | -36.28 | -20.23 | 10.1 | Upgrade |
Change in Inventory | 17.35 | -31.19 | -65.26 | -21.44 | 7.14 | Upgrade |
Change in Accounts Payable | -0.57 | 111.74 | 83.77 | 101.15 | -28.89 | Upgrade |
Change in Unearned Revenue | 17.35 | -7.5 | -2.64 | 13.1 | 6.51 | Upgrade |
Change in Other Net Operating Assets | 22.64 | 21.23 | 60.95 | -33.51 | -14.52 | Upgrade |
Operating Cash Flow | 116.4 | 56.43 | 59.93 | -175.14 | -263.12 | Upgrade |
Operating Cash Flow Growth | 106.28% | -5.84% | - | - | - | Upgrade |
Capital Expenditures | -122.8 | -197.28 | -238.98 | -112.28 | -20.49 | Upgrade |
Sale of Property, Plant & Equipment | 0.96 | 0.48 | 1.88 | 0.02 | 0.36 | Upgrade |
Sale (Purchase) of Intangibles | -0.78 | -5.92 | -1.14 | -3.03 | -1.69 | Upgrade |
Investment in Securities | 0.11 | 38.62 | -44.52 | 6.9 | 34.35 | Upgrade |
Investing Cash Flow | -122.51 | -164.11 | -282.76 | -108.39 | 12.53 | Upgrade |
Long-Term Debt Issued | 267.82 | 132.15 | 277.86 | 205.97 | - | Upgrade |
Total Debt Issued | 267.82 | 132.15 | 277.86 | 205.97 | - | Upgrade |
Long-Term Debt Repaid | -219.43 | -77.94 | -198.2 | -1.49 | -61.71 | Upgrade |
Total Debt Repaid | -219.43 | -77.94 | -198.2 | -1.49 | -61.71 | Upgrade |
Net Debt Issued (Repaid) | 48.4 | 54.21 | 79.66 | 204.47 | -61.71 | Upgrade |
Issuance of Common Stock | - | - | 405.79 | 9.61 | - | Upgrade |
Other Financing Activities | -14.21 | -15.99 | -4.21 | -2 | - | Upgrade |
Financing Cash Flow | 34.18 | 38.23 | 481.24 | 212.08 | -61.71 | Upgrade |
Foreign Exchange Rate Adjustments | 1.58 | 3.28 | 6.56 | -1.28 | -1.35 | Upgrade |
Net Cash Flow | 29.66 | -66.17 | 264.96 | -72.73 | -313.65 | Upgrade |
Free Cash Flow | -6.39 | -140.85 | -179.05 | -287.42 | -283.6 | Upgrade |
Free Cash Flow Margin | -0.58% | -18.04% | -40.49% | -376.57% | -1260.96% | Upgrade |
Free Cash Flow Per Share | -0.01 | -0.19 | -0.28 | -0.50 | -0.50 | Upgrade |
Cash Interest Paid | 14.21 | 12.61 | 6.39 | 2 | 1.79 | Upgrade |
Cash Income Tax Paid | - | 0 | - | - | - | Upgrade |
Levered Free Cash Flow | -50.79 | -150.5 | -194.28 | -303.88 | -168.12 | Upgrade |
Unlevered Free Cash Flow | -44.61 | -147.27 | -190.15 | -302.34 | -167.05 | Upgrade |
Change in Net Working Capital | 15.66 | -15.41 | -20.15 | 67.75 | 10.64 | Upgrade |
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.